401k Plan data: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN plan

SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 401k Plan overview

Plan Name	SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN
Plan identification number	001

SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 403(b)(1) arrangement - See Limited Pension Plan Reporting instructions for Code section 403(b)(1) arrangements for certain exempt organizations.
Code section 403(b)(7) accounts - See Limited Pension Plan Reporting instructions for Code section 403(b)(7) custodial accounts for regulated investment company stock for certain exempt organizations.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH has sponsored the creation of one or more 401k plans.

Company Name: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH

Employer identification number (EIN): 911452438

NAIC Classification: 541700

Additional information about SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH

Jurisdiction of Incorporation: Washington Secretary of State Corporations Division

Incorporation Date: 1989-06-22

Company Identification Number: 601187024

Legal Registered Office Address: 1660 S COLUMBIAN WAY STE 151F

SEATTLE
United States of America (USA)
981081532

More information about SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH

Form 5500 Filing Information

Submission information for form 5500 for 401k plan SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 DANIELLE FLEUMER
001 2016-01-01 DANIELLE FLEUMER
001 2015-01-01 DANIELLE BELISLE
001 2014-01-01 DANIELLE BELISLE
001 2013-01-01 DANIELLE BELISLE
001 2012-01-01 EILEEN LENNON PHD
001 2011-01-01 DANIELLE BELISLE
001 2010-01-01 DANIELLE BELISLE

Plan Statistics for SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN

401k plan membership statisitcs for SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN

Measure Date Value
2022: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 342
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 101
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 222
Total of all active and inactive participants 2022-01-01 323
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 323
Number of participants with account balances 2022-01-01 245
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 319
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 94
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 248
Total of all active and inactive participants 2021-01-01 342
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 342
Number of participants with account balances 2021-01-01 342
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 360
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 93
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 226
Total of all active and inactive participants 2020-01-01 319
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 319
Number of participants with account balances 2020-01-01 319
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 315
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 92
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 268
Total of all active and inactive participants 2019-01-01 360
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 360
Number of participants with account balances 2019-01-01 334
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 315
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 97
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 217
Total of all active and inactive participants 2018-01-01 314
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 1
Total participants 2018-01-01 315
Number of participants with account balances 2018-01-01 315
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 336
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 89
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 226
Total of all active and inactive participants 2017-01-01 315
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 315
Number of participants with account balances 2017-01-01 343
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 310
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 83
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 252
Total of all active and inactive participants 2016-01-01 335
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 1
Total participants 2016-01-01 336
Number of participants with account balances 2016-01-01 362
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 312
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 84
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 226
Total of all active and inactive participants 2015-01-01 310
Total participants 2015-01-01 310
Number of participants with account balances 2015-01-01 362
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 313
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 90
Number of retired or separated participants receiving benefits 2014-01-01 1
Number of other retired or separated participants entitled to future benefits 2014-01-01 221
Total of all active and inactive participants 2014-01-01 312
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 312
Number of participants with account balances 2014-01-01 275
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 307
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 117
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 195
Total of all active and inactive participants 2013-01-01 312
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 1
Total participants 2013-01-01 313
Number of participants with account balances 2013-01-01 310
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 293
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 132
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 174
Total of all active and inactive participants 2012-01-01 306
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 1
Total participants 2012-01-01 307
Number of participants with account balances 2012-01-01 304
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0
2011: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 261
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 143
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 149
Total of all active and inactive participants 2011-01-01 292
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 1
Total participants 2011-01-01 293
Number of participants with account balances 2011-01-01 290
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 0
2010: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 109
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 135
Number of retired or separated participants receiving benefits 2010-01-01 0
Number of other retired or separated participants entitled to future benefits 2010-01-01 125
Total of all active and inactive participants 2010-01-01 260
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 1
Total participants 2010-01-01 261
Number of participants with account balances 2010-01-01 258
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 0

Measure	Date	Value
2022: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	342
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	101
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	222
Total of all active and inactive participants	2022-01-01	323
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	323
Number of participants with account balances	2022-01-01	245
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	319
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	94
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	248
Total of all active and inactive participants	2021-01-01	342
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	342
Number of participants with account balances	2021-01-01	342
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	360
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	93
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	226
Total of all active and inactive participants	2020-01-01	319
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	319
Number of participants with account balances	2020-01-01	319
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	315
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	92
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	268
Total of all active and inactive participants	2019-01-01	360
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	360
Number of participants with account balances	2019-01-01	334
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	315
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	97
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	217
Total of all active and inactive participants	2018-01-01	314
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	1
Total participants	2018-01-01	315
Number of participants with account balances	2018-01-01	315
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	336
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	89
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	226
Total of all active and inactive participants	2017-01-01	315
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	315
Number of participants with account balances	2017-01-01	343
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	310
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	83
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	252
Total of all active and inactive participants	2016-01-01	335
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	1
Total participants	2016-01-01	336
Number of participants with account balances	2016-01-01	362
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	312
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	84
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	226
Total of all active and inactive participants	2015-01-01	310
Total participants	2015-01-01	310
Number of participants with account balances	2015-01-01	362
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	313
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	90
Number of retired or separated participants receiving benefits	2014-01-01	1
Number of other retired or separated participants entitled to future benefits	2014-01-01	221
Total of all active and inactive participants	2014-01-01	312
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	312
Number of participants with account balances	2014-01-01	275
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	307
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	117
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	195
Total of all active and inactive participants	2013-01-01	312
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	1
Total participants	2013-01-01	313
Number of participants with account balances	2013-01-01	310
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	293
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	132
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	174
Total of all active and inactive participants	2012-01-01	306
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	1
Total participants	2012-01-01	307
Number of participants with account balances	2012-01-01	304
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0
2011: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	261
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	143
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	149
Total of all active and inactive participants	2011-01-01	292
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	1
Total participants	2011-01-01	293
Number of participants with account balances	2011-01-01	290
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	0
2010: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	109
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	135
Number of retired or separated participants receiving benefits	2010-01-01	0
Number of other retired or separated participants entitled to future benefits	2010-01-01	125
Total of all active and inactive participants	2010-01-01	260
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	1
Total participants	2010-01-01	261
Number of participants with account balances	2010-01-01	258
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	0

Financial Data on SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN

Measure	Date	Value
2022 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2022 401k financial data
Total income from all sources (including contributions)	2022-12-31	$-1,696,058
Total of all expenses incurred	2022-12-31	$398,734
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$342,014
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$1,129,097
Value of total assets at end of year	2022-12-31	$15,021,789
Value of total assets at beginning of year	2022-12-31	$17,116,581
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$56,720
Total interest from all sources	2022-12-31	$24
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$342,155
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$342,155
Administrative expenses professional fees incurred	2022-12-31	$1,125
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$666,281
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$2,018
Administrative expenses (other) incurred	2022-12-31	$1,713
Total non interest bearing cash at beginning of year	2022-12-31	$13,349
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-2,094,792
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$15,021,789
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$17,116,581
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Investment advisory and management fees	2022-12-31	$53,882
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$13,808,421
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$15,872,005
Value of interest in pooled separate accounts at end of year	2022-12-31	$159,275
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$190,564
Interest earned on other investments	2022-12-31	$24
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2022-12-31	$85,304
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2022-12-31	$83,364
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2022-12-31	$83,364
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$968,789
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$957,299
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-3,182,014
Net investment gain/loss from pooled separate accounts	2022-12-31	$14,680
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$460,798
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$342,014
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	CLARK NUBER, PS
Accountancy firm EIN	2022-12-31	911194016
2021 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2021 401k financial data
Total income from all sources (including contributions)	2021-12-31	$3,575,846
Total of all expenses incurred	2021-12-31	$1,063,845
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$1,001,465
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$1,121,347
Value of total assets at end of year	2021-12-31	$17,116,581
Value of total assets at beginning of year	2021-12-31	$14,604,580
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$62,380
Total interest from all sources	2021-12-31	$15
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Administrative expenses professional fees incurred	2021-12-31	$2,250
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$574,032
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$100,541
Administrative expenses (other) incurred	2021-12-31	$1,430
Total non interest bearing cash at end of year	2021-12-31	$13,349
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$2,512,001
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$17,116,581
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$14,604,580
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$58,700
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$15,872,005
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$13,399,602
Value of interest in pooled separate accounts at end of year	2021-12-31	$190,564
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$164,008
Interest earned on other investments	2021-12-31	$15
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$83,364
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$75,634
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$75,634
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$957,299
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$965,336
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$2,014,932
Net investment gain/loss from pooled separate accounts	2021-12-31	$439,552
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$446,774
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$1,001,465
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	CLARK NUBER, PS
Accountancy firm EIN	2021-12-31	911194016
2020 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2020 401k financial data
Total income from all sources (including contributions)	2020-12-31	$3,189,634
Total of all expenses incurred	2020-12-31	$373,478
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$328,697
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$1,228,754
Value of total assets at end of year	2020-12-31	$14,604,580
Value of total assets at beginning of year	2020-12-31	$11,788,424
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$44,781
Total interest from all sources	2020-12-31	$38,074
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$269,937
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$269,937
Administrative expenses professional fees incurred	2020-12-31	$1,125
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$508,943
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$274,688
Administrative expenses (other) incurred	2020-12-31	$3,128
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$2,816,156
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$14,604,580
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$11,788,424
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Investment advisory and management fees	2020-12-31	$40,528
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$13,399,602
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$10,579,446
Value of interest in pooled separate accounts at end of year	2020-12-31	$164,008
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$164,965
Interest earned on other investments	2020-12-31	$38,074
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$75,634
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$79,282
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$79,282
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$965,336
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$964,731
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$1,654,252
Net investment gain/loss from pooled separate accounts	2020-12-31	$-1,383
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$445,123
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$328,697
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	CLARK NUBER, PS
Accountancy firm EIN	2020-12-31	911194016
2019 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2019 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2019-12-31	$37,426
Total unrealized appreciation/depreciation of assets	2019-12-31	$37,426
Total income from all sources (including contributions)	2019-12-31	$3,047,007
Total of all expenses incurred	2019-12-31	$336,166
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$298,283
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,012,846
Value of total assets at end of year	2019-12-31	$11,788,424
Value of total assets at beginning of year	2019-12-31	$9,077,583
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$37,883
Total interest from all sources	2019-12-31	$109
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$223,917
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$223,917
Administrative expenses professional fees incurred	2019-12-31	$905
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$480,475
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$118,320
Administrative expenses (other) incurred	2019-12-31	$2,702
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$2,710,841
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$11,788,424
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$9,077,583
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$34,276
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$10,579,446
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$7,870,153
Value of interest in pooled separate accounts at end of year	2019-12-31	$164,965
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$166,536
Interest earned on other investments	2019-12-31	$109
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$79,282
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$86,789
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$86,789
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$964,731
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$954,105
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,763,913
Net investment gain/loss from pooled separate accounts	2019-12-31	$8,796
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$414,051
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$298,283
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	CLARK NUBER, PS
Accountancy firm EIN	2019-12-31	911194016
2018 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2018 401k financial data
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$150
Total income from all sources (including contributions)	2018-12-31	$225,583
Total of all expenses incurred	2018-12-31	$1,199,842
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$1,163,172
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$816,557
Value of total assets at end of year	2018-12-31	$9,077,583
Value of total assets at beginning of year	2018-12-31	$10,051,992
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$36,670
Total interest from all sources	2018-12-31	$36,146
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$233,985
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$233,985
Administrative expenses professional fees incurred	2018-12-31	$1,125
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$439,278
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$2,433
Administrative expenses (other) incurred	2018-12-31	$2,729
Liabilities. Value of operating payables at beginning of year	2018-12-31	$150
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-974,259
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$9,077,583
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$10,051,842
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$32,816
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$7,870,153
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$8,901,047
Value of interest in pooled separate accounts at end of year	2018-12-31	$166,536
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$187,930
Interest earned on other investments	2018-12-31	$36,146
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$86,789
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$86,786
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$86,786
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$954,105
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$876,229
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-869,319
Net investment gain/loss from pooled separate accounts	2018-12-31	$8,214
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$374,846
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$1,163,172
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	CLARK NUBER, PS
Accountancy firm EIN	2018-12-31	911194016
2017 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2017 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$150
Total income from all sources (including contributions)	2017-12-31	$2,071,050
Total of all expenses incurred	2017-12-31	$327,564
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$293,421
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$741,697
Value of total assets at end of year	2017-12-31	$10,051,992
Value of total assets at beginning of year	2017-12-31	$8,308,356
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$34,143
Total interest from all sources	2017-12-31	$34,844
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$220,555
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$220,555
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$380,192
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$13,667
Administrative expenses (other) incurred	2017-12-31	$2,457
Liabilities. Value of operating payables at end of year	2017-12-31	$150
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$1,743,486
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$10,051,842
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$8,308,356
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Investment advisory and management fees	2017-12-31	$28,836
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$8,901,047
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$7,150,079
Value of interest in pooled separate accounts at end of year	2017-12-31	$187,930
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$198,706
Interest earned on other investments	2017-12-31	$34,410
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$86,786
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$85,870
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$85,870
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$434
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2017-12-31	$876,229
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2017-12-31	$873,701
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$1,065,853
Net investment gain/loss from pooled separate accounts	2017-12-31	$8,101
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$347,838
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$293,421
Contract administrator fees	2017-12-31	$2,850
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	CLARK NUBER, PS
Accountancy firm EIN	2017-12-31	911194016
2016 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2016 401k financial data
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$75
Total income from all sources (including contributions)	2016-12-31	$1,203,248
Total of all expenses incurred	2016-12-31	$296,299
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$270,840
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$663,358
Value of total assets at end of year	2016-12-31	$8,308,356
Value of total assets at beginning of year	2016-12-31	$7,401,482
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$25,459
Total interest from all sources	2016-12-31	$37,205
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$135,165
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$135,165
Administrative expenses professional fees incurred	2016-12-31	$2,213
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$326,466
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$3,217
Liabilities. Value of operating payables at beginning of year	2016-12-31	$75
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$906,949
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$8,308,356
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$7,401,407
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Investment advisory and management fees	2016-12-31	$22,646
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$7,150,079
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$6,263,494
Value of interest in pooled separate accounts at end of year	2016-12-31	$198,706
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$185,925
Interest earned on other investments	2016-12-31	$37,031
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2016-12-31	$85,870
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2016-12-31	$91,705
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2016-12-31	$91,705
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2016-12-31	$174
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2016-12-31	$873,701
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2016-12-31	$860,358
Expenses. Payments to insurance carriers foe the provision of benefits	2016-12-31	$3,593
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$357,850
Net investment gain/loss from pooled separate accounts	2016-12-31	$9,670
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$333,675
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$267,247
Contract administrator fees	2016-12-31	$600
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	CLARK NUBER, PS
Accountancy firm EIN	2016-12-31	911194016
2015 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2015 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$75
Total income from all sources (including contributions)	2015-12-31	$673,013
Total of all expenses incurred	2015-12-31	$331,283
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$308,578
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$666,732
Value of total assets at end of year	2015-12-31	$7,401,482
Value of total assets at beginning of year	2015-12-31	$7,059,677
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$22,705
Total interest from all sources	2015-12-31	$9
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$142,640
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$142,640
Administrative expenses professional fees incurred	2015-12-31	$1,817
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$312,795
Liabilities. Value of operating payables at end of year	2015-12-31	$75
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$341,730
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$7,401,407
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$7,059,677
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Investment advisory and management fees	2015-12-31	$20,115
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$6,263,494
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$5,893,388
Value of interest in pooled separate accounts at end of year	2015-12-31	$185,925
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$175,999
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2015-12-31	$91,705
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$77,328
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$77,328
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-12-31	$9
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2015-12-31	$860,358
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2015-12-31	$910,773
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-150,612
Net investment gain/loss from pooled separate accounts	2015-12-31	$14,244
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$353,937
Employer contributions (assets) at beginning of year	2015-12-31	$2,189
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$308,578
Contract administrator fees	2015-12-31	$773
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	CLARK NUBER, PS
Accountancy firm EIN	2015-12-31	911194016
2014 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2014 401k financial data
Total income from all sources (including contributions)	2014-12-31	$2,163,413
Total of all expenses incurred	2014-12-31	$183,778
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$162,031
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$1,778,545
Value of total assets at end of year	2014-12-31	$7,059,677
Value of total assets at beginning of year	2014-12-31	$5,080,042
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$21,747
Total interest from all sources	2014-12-31	$37,727
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$395,968
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$980,155
Administrative expenses (other) incurred	2014-12-31	$1,072
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$1,979,635
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$7,059,677
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$5,080,042
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Investment advisory and management fees	2014-12-31	$20,000
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$5,893,388
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$3,846,223
Value of interest in pooled separate accounts at end of year	2014-12-31	$175,999
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$321,160
Interest earned on other investments	2014-12-31	$37,724
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$77,328
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$3
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2014-12-31	$910,773
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2014-12-31	$912,659
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$322,839
Net investment gain/loss from pooled separate accounts	2014-12-31	$24,302
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$402,422
Employer contributions (assets) at end of year	2014-12-31	$2,189
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$162,031
Contract administrator fees	2014-12-31	$675
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2014-12-31	911194016
2013 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2013 401k financial data
Total income from all sources (including contributions)	2013-12-31	$1,100,124
Total of all expenses incurred	2013-12-31	$177,746
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$177,379
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$524,413
Value of total assets at end of year	2013-12-31	$5,080,042
Value of total assets at beginning of year	2013-12-31	$4,157,664
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$367
Total interest from all sources	2013-12-31	$35,841
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$116,485
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$922,378
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$5,080,042
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$4,157,664
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$3,846,223
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$3,039,392
Value of interest in pooled separate accounts at end of year	2013-12-31	$321,160
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$265,690
Interest earned on other investments	2013-12-31	$35,841
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2013-12-31	$912,659
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2013-12-31	$852,582
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$513,006
Net investment gain/loss from pooled separate accounts	2013-12-31	$26,864
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$407,928
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$177,379
Contract administrator fees	2013-12-31	$367
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2013-12-31	911194016
2012 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2012 401k financial data
Total income from all sources (including contributions)	2012-12-31	$877,142
Total of all expenses incurred	2012-12-31	$264,970
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$264,970
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$540,886
Value of total assets at end of year	2012-12-31	$4,157,664
Value of total assets at beginning of year	2012-12-31	$3,545,492
Total interest from all sources	2012-12-31	$33,063
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$1,000,000
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$117,142
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$612,172
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$4,157,664
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$3,545,492
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$3,039,392
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$2,533,356
Value of interest in pooled separate accounts at end of year	2012-12-31	$265,690
Value of interest in pooled separate accounts at beginning of year	2012-12-31	$233,506
Interest earned on other investments	2012-12-31	$33,063
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2012-12-31	$852,582
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2012-12-31	$778,630
Expenses. Payments to insurance carriers foe the provision of benefits	2012-12-31	$8,679
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$279,180
Net investment gain/loss from pooled separate accounts	2012-12-31	$24,013
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$423,744
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$256,291
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2012-12-31	911194016
2011 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2011 401k financial data
Total income from all sources (including contributions)	2011-12-31	$526,078
Total of all expenses incurred	2011-12-31	$103,426
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$103,426
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$495,579
Value of total assets at end of year	2011-12-31	$3,545,492
Value of total assets at beginning of year	2011-12-31	$3,122,840
Total interest from all sources	2011-12-31	$30,403
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$106,271
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$422,652
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$3,545,492
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$3,122,840
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$2,533,356
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$2,241,146
Value of interest in pooled separate accounts at end of year	2011-12-31	$233,506
Value of interest in pooled separate accounts at beginning of year	2011-12-31	$186,264
Interest earned on other investments	2011-12-31	$30,403
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2011-12-31	$778,630
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2011-12-31	$695,430
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-25,506
Net investment gain/loss from pooled separate accounts	2011-12-31	$25,602
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$389,308
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$103,426
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2011-12-31	911194016
2010 : SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH 403(B) DC PLAN 2010 401k financial data
Total transfer of assets to this plan	2010-12-31	$757,968
Total income from all sources (including contributions)	2010-12-31	$751,625
Total of all expenses incurred	2010-12-31	$164,901
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$164,901
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$479,556
Value of total assets at end of year	2010-12-31	$3,122,840
Value of total assets at beginning of year	2010-12-31	$1,778,148
Total interest from all sources	2010-12-31	$28,787
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$102,114
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$8,965
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$586,724
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$3,122,840
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$1,778,148
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$2,241,146
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$1,196,489
Value of interest in pooled separate accounts at end of year	2010-12-31	$186,264
Value of interest in pooled separate accounts at beginning of year	2010-12-31	$89,350
Interest earned on other investments	2010-12-31	$28,787
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2010-12-31	$695,430
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2010-12-31	$492,309
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$222,008
Net investment gain/loss from pooled separate accounts	2010-12-31	$21,274
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$368,477
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$164,901
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2010-12-31	911194016